Summary
The New York Supreme Court valued an over the counter pharmaceutical company for a buyout under BCL sec 1118. The court rejected valuations using the liquidation and analytic pricing models, and accepted a valuation of the business using the capitalizatio ...
Matter of Wolk v. Vetco, Inc.
PDF, Size: 57 KB
See Also
Illiquidity Discount Applied in Addition to Company-Specific Risk Adjustment in the Capitalization Rate
The New York Supreme Court valued an over-the-counter pharmaceutical company for a buyout under BCL sec 1118.